Skip to content
IM Injection Allopathic

Vaxitet 40 IU/0.5 ml im injection

Generic: Adsorbed Tetanus Vaccine

Company: Incepta Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength40 IU/0.5 ml
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated January 14, 2025.

Compare

Same generic, same strength

Sorted by price per im injection. Ask your pharmacist before you switch brands.

Adsorbed Tetanus Vaccine 40 IU/0.5 ml im injections

Prices as listed on BestinMeds.

2 brands listed
Vaxitet, box of 10 (this medicine)60.00 taka per im injection
TT vax, box of 595.00 taka per im injection

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Adsorbed Tetanus Vaccine guide

Indications

Tetanus For the active immunization of infants, children 7 years of age or older and adults against tetanus, wherever combined antigen preparations are not indicated. For the prevention of neonatal tetanus in infants by immunizing women of childbearing age or infants bom of unvaccinated pregnant women. ... Read more For the active immunization of infants, children 7 years of age or older and adults against tetanus, wherever combined antigen preparations are not indicated. For the prevention of neonatal tetanus in infants by immunizing women of childbearing age or infants bom of unvaccinated pregnant women. Those who are liable to be exposed to tetanus infection and persons engaged in outdoor activities e.g. gardeners, agricultural, veterinary, athletes, industrial, sewage, road and outdoor workers, etc. This vaccine is not to be used for the treatment of tetanus infection. If passive immunization is required, Tetanus Immunoglobulin (TIG) should be used.

Dosage and administration

Primary immunization for persons 7 years of age and older- A series of three doses of 0.5 ml each, of adsorbed tetanus vaccine should be given intramuscularly First dose: At appropriate date Second dose: 4 to 8 weeks after the first dose Third dose: 6 to 12 months after the second dose Children older than 7 years who did not complete primary immunization series (e.g., previously received only two doses of DTaP or DTP) need to receive only one dose of tetanus toxoid adsorbed vaccine to complete the primary series of tetanus. Interruption of the recommended schedule with a delay between doses does not interfere with the final immunity achieved with adsorbed tetanus vaccine. There is no need to start the series over again, regardless of the time elapsed between doses. Routine booster injections: To maintain adequate protection, a booster dose of 0.5 ml of adsorbed tetanus vaccine every 10 years thereafter is recommended. Vaccination of injured persons- Clean and minor wound: If primary immunization confirmed and receiving booster dose within previous 5 years, no need of additional vaccine. If primary immunization confirmed and receiving booster dose more than previous 5 years, 1 dose of 0.5 ml required. All other dirty wounds (contaminated with feces, soil, and saliva): If primary immunization confirmed and receiving booster dose within previous 5 years, 1 dose of 0.5 ml required. If primary immunization confirmed and receiving booster dose more than previous 5 years, 1 dose of 0.5 ml along with tetanus immunoglobulin required. If a person has no previous vaccination or uncertain, the primary series of 3 doses of 0.5ml adsorbed tetanus vaccine should be given along with tetanus immunoglobulin with 1st dose. Protection of neonatal tetanus- For prevention of neonatal tetanus, adsorbed tetanus vaccine is recommended for immunization of women of childbearing age. Women (15-49 Years): For pregnant woman who have not had previous immunization, 2 doses of tetanus toxoid at four weeks interval preferably during the last two trimester or at least 2 weeks before delivery should be given during pregnancy so that protective antibody would be transferred to the infant in order to prevent neonatal tetanus, e.g. 1 dose of 0.5 ml at 6th month of pregnancy and 1 dose of 0.5 ml at 7th month of pregnancy. Pregnant woman who have completed the course of tetanus, next 10 years no need of additional dose during pregnancy. Thereafter a single booster dose would be sufficient to extend immunity.

Side effects

Adsorbed tetanus vaccine is generally well tolerated. Most recipients of tetanus vaccine experience some reactions upon vaccination. These are generally moderate and short in duration. They mainly consist of local reactions at the injection site (erythema, induration and tenderness). Systemic reactions (malaise and elevated temperature) are reported less commonly.

Precautions and warnings

Do not administer IV. Use subcutaneous route in bleeding disorders. Withhold vaccination in moderate or severe febrile illness. Pregnancy, lactation, history of Guillian-Barre syndrome.

Pregnancy and lactation

For protection of neonatal tetanus, tetanus toxoid is recommended for immunization of women of childbearing age and especially pregnant women. Tetanus toxoid may be safely administered during pregnancy and should be given to the mother at first contact or as early as possible. It is not known if tetanus toxoid is excreted in human milk. It may be administered to nursing mothers only if clearly needed.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250